TrialThe New England journal of medicine2020
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer.
Shanu Modi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1,130 papers cite itlatest 60 shown
this paperpooled ittrialcites it